QUANTIFICATION OF GALLIC ACID AND ELLAGIC ACID IN ARJUNARISHTA BY VALIDTAED HPTLC DENSITOMETRY
HTML Full TextQUANTIFICATION OF GALLIC ACID AND ELLAGIC ACID IN ARJUNARISHTA BY VALIDTAED HPTLC DENSITOMETRY
Preeti Tiwari*1 and Rakesh K. Patel 2
Department of Pharmacognosy, Shri Sarvajanik Pharmacy College 1, Mehsana-384001, Gujarat, India
Department of Pharmacognosy, Shri S.K. Patel College of Pharmaceutical Education and Research 2, Kherva-382711, Gujarat, India
ABSTRACTArjunarishta, also known as Parthadhyarishta, is a polyherbal hydro alcoholic formulation and is advised as a choice of remedy in cardiovascular disorders. A simple, precise and accurate HPTLC method has been established for the determination of quercetin and rutin in Arjunarishta–T and Arjunarishta-M prepared by traditional and modern methods respectively and also in its marketed formulation. The developed HPTLC method was validated in terms of precision, accuracy, LOD, LOQ, specificity, robustness and ruggedness. The amount of gallic acid in Arjunarishta-T, M and its marketed formulation was found to be 0.0332, 0.0331 and 0.0330% w/w respectively while ellagic acid was found to be 0.0361, 0.0360 and 0.0359% w/w respectively. This is the first report for the quantification of gallic acid and ellagic acid in Arjunarishta by HPTLC. Furthermore, no TLC densitometric methods have been reported for the quantification of gallic acid and ellagic acid from Arjunarishta
Keywords:
HPTLC, Validation, Gallic acid, Ellagic acid, |
Arjunarishta
INTRODUCTION:Ayurveda, taken from the Sanskrit words Ayur meaning life or lifespan and Veda meaning knowledge, originated in India but is now practicised throughout the world 1. There has been increasing interest in Ayurveda, particularly its botanical remedies, because several Indian traditional herbs have been found to produce potent anti-tumour and immunologic effects 2.
Arishtas are an important group of formulations used in Ayurveda. Arjunarishta, also named as Parthadhyarishta, is a poly-herbal hydro-alcoholic formulation. The chief ingredient of Arjunarishta is dried stem bark of Terminalia arjuna Roxb. It contains hydrolysable tannins, triterpenoid glycosides (arjunglucoside-1, arjunglucoside-2), and sapogenins as arjunic acid, arjunolic acid, cardenolides, phenolics, flavonoids, phyto-sterols, mineral salt and sugar 3.
It also contains Draksha (fruits of Vitis vinifera) and madhuca flowers (flowers of Bassia longifolia) which are the rich source of phenolic compounds and possess good antioxidant activity. All these ingredients are used as good dietary sources of antioxidants 4-6.
The major ingredient of Arjunarishta is stem bark of Terminalia arjuna. The stem bark of Terminalia arjuna has been used for alleviating angina and other cardiovascular conditions 7. The extract also improved the symptoms of refractory chronic congestive heart failure 8.
Oral administration of Terminalia arjuna bark also prevented ischemic reperfusion injury induced oxidative stress and tissue injury of heart in rabbits indicating its beneficial therapeutic effect in ischemic heart disease 9.
The flavonoids which are found present in Terminalia arjuna bark have shown antioxidant and lipid lowering effect 10. HPLC analysis has been carried out for the quantification of some marker compounds for the standardization of Arjunarishta 11. Furthermore, no validated HPTLC method has been reported for the quantification of gallic acid and ellagic acid from Arjunarishta.
Standardization is an important aspect for establishing the quality and efficacy of Ayurvedic formulations or any poly herbal formulation. Therefore, a proper scientific validation as chromatographic fingerprinting is required for quantification of marker compounds for quality control purposes.
MATERIALS AND METHODS:
Preparation of Arjunarishta-T: The ingredients of Arjunarishta as Arjuna bark (Terminalia arjuna), fruits of Draksha (Vitis vinifera) and madhuca flowers (Bassia longifolia) were procured from local market, Jamnagar. Identification of all the individual plant material was done as per Ayurvedic Pharmacopoeia of India. Authentification of all these ingredients was done in the Department of Botany of Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow. Prepared herbarium has been deposited in the CIMAP for future reference.
It was prepared by traditional method as given in The Ayurvedic Formulary of India, part- I, 200012. According to this method, coarsely powdered Arjuna bark (Terminalia arjuna), fruits of Draksha (Vitis vinifera) and madhuca flowers (Bassia longifolia) were placed in polished vessel of brass along with prescribed quantity of water (26L), and allowed to steep overnight.
After overnight steeping this material was warmed at medium flame until the water for decoction reduced to one fourth of the prescribed quantity (6.5 L), then the heating was stopped and liquor was filtered in a cleaned vessel and then 2.5kg of Jaggery (concentrated juice of Saccharum officinarum) was added and mixed properly. This sweet filtered liquor was placed in incubator for 15 days at 33°C±1°C after adding Dhataki flowers (Woodfordia floribunda). After 15 days, completion of fermentation was confirmed by standard tests 13.
The fermented preparation was filtered with unstarched muslin cloth and kept in cleaned covered vessel for further next seven days. Then, it was poured in clean amber coloured glass bottles previously rinsed with ethyl alcohol, packed and labelled properly.
Preparation of Arjunarishta-M: It was prepared by modern method by carrying slight modifications in the traditional method. Method of preparation was same as followed with Arjunarishta-T, only Dhataki flowers were replaced by Yeast for inducing fermentation 14.
Reagents and Materials: All solvents used were of analytical grade and were purchased from Merck. Gallic acid (purity98%) was purchased from SD fine, Mumbai. Ellagic acid (purity 97%) was purchased from Yucca Enterprises, Mumbai, India.
HPTLC: Chromatography was performed on 20 x 10 cm HPTLC plates coated with 0.25 mm layers of silica gel 60 F254 (Merck, Darmstadt, Germany). Before use the plates were washed with methanol and activated at 110ºC for 5 min. Samples were applied as bands 4 mm wide and 6 mm apart by use of Desaga (Ziegel Wiesen, Germany) AS 30 Win sample applicator equipped with a 100 µL syringe. A constant application rate of 10µL s-1 was used. The mobile phase for gallic acid was toluene- ethyl acetate- formic acid- methanol, 6+6+1.2+0.25 (v/v), while for ellagic acid was toluene-ethyl acetate-formic acid-methanol, 9+9+3+0.6 (v/v), were used for chromatography.
Linear ascending development was performed in a Camag 20cm x 10cm glass twin-trough chamber. Before insertion of the plate the chamber was saturated with mobile phase vapor for 20 min at room temperature (25±2oC) and relative humidity 60 ± 5% by lining the TLC chamber on three sides with filter paper, also placed in the mobile phase. The development distance was 8 cm. After development the TLC plates were dried in a current of air by means of an air dryer.
Densitometric scanning was performed with a Desaga TLC scanner CD 60 in reflectance absorbance mode at λ = 290 nm for gallic acid and λ = 285 nm for ellagic acid controlled by ProQuant software (v1.06; Desaga) resident in the system. The slit dimensions were 4 x 0.02 mm and the scanning speed 100 nm s-1. The radiation source was a deuterium lamp emitting continuous UV radiation between 190-360 nm.
The amounts of the compounds chromatographed were determined from the intensity of diffusely reflected light.
Preparation of Standard Solutions and Calibration Plots:
- Preparation of standard solution of gallic acid: Stock solution of 300 µg mL-1 of gallic acid was prepared by dissolving 15 mg of accurately weighed gallic acid in methanol and making the volume of solution up to 50 mL with methanol in volumetric flask. The aliquots (0.5 to 2.5 mL) of stock solutions were transferred to 10 mL volumetric flasks and the volume of each was adjusted to 10 mL with methanol, to obtain standard solutions containing 15, 30, 45, 60 and 75 µg mL-1 of gallic acid, respectively.
10µL each of the standard solutions of gallic acid (150-750 ng spot-1) were applied as bands 4 mm wide and 6 mm apart in triplicate on a TLC plate using an automatic sample spotter (AS 30 Win). Linear regression data for the calibration plot are listed in Table 1. A good linear relationship between response (peak area) and amount was obtained over the range 150-750 ng/band.
- Preparation of standard solution of ellagic acid: Stock solution of 400 µg mL-1 of ellagic acid was prepared by dissolving 20 mg of accurately weighed ellagic acid in methanol and making the volume of solution up to 50 mL with methanol in volumetric flask. The aliquots (0.5 to 2.5 mL) of stock solutions were transferred to 10 mL volumetric flasks and the volume of each was adjusted to 10 mL with methanol, to obtain standard solutions containing 20, 40, 60, 80 and 100µg mL-1 of ellagic acid, respectively.
10µL each of the standard solutions of ellagic acid (200-1000 ng spot-1) were applied as bands 4 mm wide and 6 mm apart in triplicate on a TLC plate using an automatic sample spotter (AS 30 Win). Linear regression data for the calibration plot are listed in Table 1. A good linear relationship between response (peak area) and amount was obtained over the range 200-1000 ng/band.
Sample Preparation: 1 g (equivalent to 0.94 mL) of each of the test formulation of Arjunarishta as Arjunarishta-T, Arjunarishta-M and its marketed formulation was dried on water bath for half an hour to remove the alcohol. Then, each of the test samples of Arjunarishta was diluted with methanol up to 10 mL and sonicated for 15 min and centrifuged at 3200 rpm to settle down the precipitated sugars. 1 mL of supernatant was passed through 0.45 µm filter (Millipore) and 10µL of each of the test formulation was applied as band on plate for quantification.
Validation of the method: ICH guidelines were followed for the validation of analytical methods developed for precision, repeatability and accuracy15.
RESULTS AND DISCUSSION:
Selection of the optimum mobile phase: In an attempt to optimize mobile phase, toluene-ethyl acetate-formic acid-methanol mixtures in different proportions were investigated. Use of toluene-ethyl acetate-formic acid-methanol 6+6+1.2+0.25(v/v) resulted in sharp, well defined gallic acid peaks of RF 0.49±0.02 while solvent system toluene-ethyl acetate-formic acid-methanol 9+9+3+0.6(v/v) resulted in sharp ellagic acid peaks of RF 0.46±0.02.Well defined bands were obtained only when the chamber was saturated with the mobile phase for 30 min at room temperature before plate development.
Results of Validation of the method: ICH guidelines were followed for the validation of the analytical methods developed for precision, repeatability and accuracy and the results have been shown as follows.
Instrumental precision: Instrumental precision was checked by repeated scanning (n = 6) of the same spot of gallic acid (150 ng spot-1) and ellagic acid (200 ng spot -1) expressed as relative standard deviation (% RSD) as shown in Table 1.
Repeatability: The repeatability of method was affirmed by analysing 150 ng spot-1 and 200 ng spot-1 individually on TLC plate (n = 6) and expressed as % RSD as shown in Table 1.
LOD and LOQ: The limits of detection and quantification were determined by visual evaluation. The detection and quantification limits obtained by this method for gallic acid were 50 and 150 ng, respectively while for ellagic acid detection and quantification limit were 60 and 200 ng respectively as shown in Table 1 which indicates that the sensitivity of the method is adequate.
TABLE 1: METHOD VALIDATION PARAMETERS FOR THE QUANTIFICATION OF GALLIC ACID AND ELLAGIC ACID IN ARJUNARISHTA-T, ARJUNARISHTA-M AND ITS MARKETED FORMULATION
Parameter | Gallic acid | Ellagic acid |
Instrumental Precision (% RSD, n = 6) | 0.54 | 1.08 |
Repeatability (% RSD, n = 6) | 0.58 | 1.15 |
LOD (ng) | 50 | 60 |
LOQ (ng) | 150 | 200 |
Linear range (n = 3) | 150-750 ng/band | 200-1000 ng/band |
Correlation coefficient (r) | 0.9996 | 0.9996 |
Slope | 6715.2 | 2233.3 |
Intra-day and Inter-day Precision: The intra-day and inter-day precision of the method were estimated by analysing aliquots of standard solution containing 150, 450, 750 ng spot-1 and 200, 600, 1000 ng spot-1 of ellagic acid on the same day (intra-day precision) and on different days (inter-day precision) and the results were expressed as % RSD in Table 2 16.
TABLE 2: INTRA-DAY AND INTER-DAY PRECISION OF THE HPTLC METHOD (a)
Marker | Amount [ng/band] | Intra-day precision | Inter-day precision | ||
Mean area [AU] | RSD [%] | Mean area [AU] | RSD [%] | ||
Gallic acid | 150 | 2913.9 | 0.55 | 2912.1 | 0.64 |
450 | 4910.6 | 0.41 | 4909.5 | 0.48 | |
750 | 6952.9 | 0.34 | 6951.2 | 0.42 | |
Ellagic acid | 200 | 1410.8 | 1.15 | 1409.7 | 1.34 |
600 | 2275.4 | 0.90 | 2274.0 | 1.13 | |
1000 | 3197.6 | 0.60 | 3196.2 | 0.69 |
(a) n = 6
Specificity: The specificity of the method was ascertained by analyzing reference standard and samples. The bands for gallic acid and ellagic acid from Arjunarishta-T, Arjunarishta-M and its marketed formulations were confirmed by comparing the RF and UV spectra of the separated bands with those from the standard.
Recovery: The pre-analyzed samples of Arjunarishta-T, Arjunarishta-M and its marketed formulation were spiked with an additional 50, 100 and 150% of gallic acid standard and the mixtures were analysed again, in triplicate, by the proposed method, to check recovery of different amounts of gallic acid from the Arjunarishta-T, Arjunarishta-M and its marketed formulation. Recovery was found in between 99.86-100.15% in Arjunarishta-T, 100.06-100.10% in Arjunarishta-M and 99.80-100.13% in the marketed formulation of Arjunarishta as depicted in Table 3.
TABLE 3: RESULTS OF RECOVERY STUDY OF GALLIC ACID FROM ARJUNARISHTA-T, M AND ITS MARKETED FORMULATION (n= 3)
Sample | Amount of drug added [%] | Theoretical content [ng] | Recovery [%] | RSD [%] |
Arjunarishta-T | 50 | 498 | 99.86 | 0.31 |
100 | 664 | 100.15 | 0.46 | |
150 | 830 | 100.12 | 0.43 | |
Arjunarishta-M | 50 | 496 | 100.06 | 0.42 |
100 | 662 | 100.10 | 0.48 | |
150 | 827 | 100.08 | 0.39 | |
Marketed Arjunarishta | 50 | 495 | 100.13 | 0.65 |
100 | 660 | 99.95 | 0.32 | |
150 | 825 | 99.80 | 0.30 |
Similarly, the analyzed samples of Arjunarishta-T, M and its marketed formulation were spiked with an additional 50, 100 and 150% of ellagic acid standard and the mixtures were analysed again, in triplicate, by the proposed method, to check the recovery of different amounts of ellagic acid from Arjunarishta-T, M and its marketed formulation. Recovery was found in between 99.82-99.93% in Arjunarishta-T, 99.89-100.23% and 100.04-100.13% in marketed Arjunarishta as shown in Table 4.
TABLE 4: RESULTS OF RECOVERY STUDY OF ELLAGIC ACID FROM ARJUNARISHTA-T, M AND ITS MARKETED FORMULATION (N = 3)
Sample | Amount of drug added [%] | Theoretical content [ng] | Recovery [%] | RSD [%] |
Arjunarishta-T | 50 | 542 | 99.82 | 0.37 |
100 | 722 | 99.86 | 0.50 | |
150 | 903 | 99.93 | 0.28 | |
Arjunarishta-M | 50 | 540 | 100.19 | 0.49 |
100 | 720 | 100.23 | 0.45 | |
150 | 900 | 99.89 | 0.51 | |
Marketed Arjunarishta | 50 | 538 | 100.13 | 0.47 |
100 | 718 | 100.05 | 0.43 | |
150 | 898 | 100.04 | 0.23 |
Robustness: Robustness was checked by performing analysis of sample solutions of Arjunarishta as Arjunarishta-T, Arjunarishta-M and its marketed formulation after making small changes to mobile-phase composition toluene-ethyl acetate-formic acid-methanol 6 + 6 + 1.2 + 0.25 and 6.2 + 5.8 + 1.2 + 0.25 (v/v) were tried with two different development distances, 8 and 9 cm for two different amounts of gallic acid, 498 and 830 ng per band from Arjunarishta-T, 496 and 827 ng per band from Arjunarishta-M and 495 and 825 ng per band from its marketed formulation 17.
The low values of % RSD were obtained after introduction of these small changes as shown in Table 5. Similarly, robustness was also evaluated by analysing Arjunarishta-T, M and its marketed formulation after making slight changes to mobile-phase composition toluene-ethyl acetate-formic acid 9 + 9 + 3 + 0.6 and 9.2 + 8.8 + 2.9 + 0.6 (v/v) were tried with two different development distances, 8 and 9 cm for two different amounts of ellagic acid, 542 and 903 ng per band from Arjunarishta-T, 540 and 900 ng per band from Arjunarishta-M and 539 and 898 ng per band from its marketed formulation.
Thus, low values of % RSD obtained after introduction of these small changes were indicative of the robustness of the method (Table 6).
TABLE 5: ROBUSTNESS OF THE METHOD FOR GALLIC ACID A)
Condition | Arjunarishta-T | Arjunarishta-M | Marketed Arjunarishta | |||
Recovery [%]b) | RSD [%]b) | Recovery [%]c) | RSD [%]c) | Recovery [%]d) | RSD [%]d) | |
Mobile phase composition e) | ||||||
T-EA-FA-M (6 + 6 + 1.2 + 0.25) | 100.12 | 0.45 | 100.05 | 0.53 | 99.92 | 0.65 |
T-EA-FA-M (6.2 + 5.8 + 1.2 + 0.25) | 100.09 | 0.94 | 100.02 | 0.79 | 99.90 | 0.98 |
Development distance | ||||||
8 cm | 100.14 | 0.51 | 100.06 | 0.49 | 99.95 | 0.58 |
9 cm | 100.08 | 0.89 | 100.03 | 1.12 | 99.87 | 1.09 |
a) n = 6
b) Average for two amounts, 498 and 830 ng/band
c) Average for two amounts, 496 and 827 ng/band
d) Average for two amounts, 495 and 825 ng/band
e) T, toluene; EA, ethyl acetate; FA, formic acid; M, methanol
TABLE 6: ROBUSTNESS OF THE METHOD FOR ELLAGIC ACID A)
Condition | Arjunarishta-T | Arjunarishta-M | Marketed Arjunarishta | |||
Recovery [%]b) | RSD [%]b) | Recovery [%]c) | RSD [%]c) | Recovery [%]d) | RSD [%]d) | |
Mobile phase composition e) | ||||||
T-EA-FA-M (9 + 9 + 3 + 0.6) | 99.89 | 0.54 | 100.15 | 0.62 | 100.04 | 0.76 |
T-EA-FA-M (9.2 + 8.8 + 2.9 + 0.6) | 99.82 | 0.69 | 100.11 | 0.73 | 100.02 | 0.56 |
Development distance | ||||||
8 cm | 99.93 | 0.61 | 100.13 | 0.56 | 100.08 | 0.82 |
9 cm | 99.89 | 0.77 | 100.11 | 0.86 | 100.05 | 0.94 |
a) n = 6
b) Average for two amounts, 542 and 903 ng/band
c) Average for two amounts, 540 and 900 ng/band
d) Average for two amounts, 539 and 898 ng/band
e) T, toluene; EA, ethyl acetate; FA, formic acid; M, methanol
Ruggedness: Ruggedness is a measure of the reproducibility of a test result under normal, expected operating conditions from instrument to instrument and from analyst to analyst. Ruggedness was tested by analysis of gallic acid 498 and 830 ng per band from Arjunarishta-T, 496 and 827 ng per band from Arjunarishta-M and 495 and 825 ng per band from its marketed formulation; the results are listed in Table 7 17. Similarly, ruggedness was measured by performing the analysis of ellagic acid 542 and 903 ng per band from Arjunarishta-T, 540 and 900 ng per band from Arjunarishta-M and 539 and 898 ng per band from its marketed formulation as shown in Table 8.
TABLE 7: RUGGEDNESS OF THE METHOD FOR GALLIC ACID A)
Variable | Arjunarishta-T | Arjunarishta-M | Marketed Arjunarishta | |||
Recovery [%]b) | RSD [%]b) | Recovery [%]c) | RSD [%]c) | Recovery [%]d) | RSD [%]d) | |
Analyst I | 100.10 | 0.39 | 100.06 | 0.71 | 99.95 | 0.69 |
Analyst II | 99.98 | 0.59 | 100.02 | 0.61 | 99.98 | 0.46 |
a) n = 6
b) Average for two amounts, 498 and 830 ng/band
c) Average for two amounts, 496 and 827 ng/band
d) Average for two amounts, 495 and 825 ng/band
TABLE 8: RUGGEDNESS OF THE METHOD FOR ELLAGIC ACID A)
Variable | Arjunarishta-T | Arjunarishta-M | Marketed Arjunarishta | |||
Recovery [%]b) | RSD [%]b) | Recovery [%]c) | RSD [%]c) | Recovery [%]d) | RSD [%]d) | |
Analyst I | 99.93 | 0.64 | 100.09 | 0.78 | 100.01 | 0.89 |
Analyst II | 100.02 | 0.48 | 100.11 | 0.57 | 100.04 | 0.68 |
a) n = 6
b) Average for two amounts, 542 and 903 ng/band
c) Average for two amounts, 540 and 900 ng/band
d) Average for two amounts, 539 and 898 ng/band
Estimation of gallic acid and ellagic acid in Arjunarishta-T, Arjunarishta-M and in its marketed formulation: Gallic acid was found to be 0.0332, 0.0331 and 0.0330 %w/w in Arjunarishta-T, M and its marketed formulation respectively while ellagic acid was found to be 0.0361, 0.0360 and 0.0359 %w/w in Arjunarishta-T, Arjunarishta-M and in marketed Arjunarishta respectively as showed in Table 9.
TABLE 9: ESTIMATION OF GALLIC ACID AND ELLAGIC ACID FROM ARJUNARISHTA-T, ARJUNARISHTA-M AND ITS MARKETED FORMULATION BY PROPOSED HPTLC METHOD
Sample | Gallic acid (% w/w)a) | Ellagic acid (% w/w)a) |
Arjunarishta-T | 0.0332 ± 0.0002 | 0.0361 ± 0.0002 |
Arjunarishta-M | 0.0331 ± 0.0003 | 0.0360 ± 0.0002 |
Marketed Arjunarishta | 0.0330 ± 0.0002 | 0.0359 ± 0.0003 |
(a) Mean ± SD, n = 3
The suitability of the method was examined by estimation of gallic acid in Arjunarishta-T, M and its marketed formulation. Bands of RF 0.49 ± 0.02 were observed in the densitogram for gallic acid standard (Figure 1) while the bands of same RF were observed in the densitogram obtained from the gallic acid isolated from Arjunarishta-T, M and its marketed formulation (Figure 2). Similarly, ellagic acid was also estimated in Arjunarishta-T, M and its marketed formulation. Bands of RF 0.46 ± 0.02 were observed in the densitogram for ellagic acid standard (Figure 3) while the bands of same RF were observed in the densitogram obtained from ellagic acid isolated from Arjunarishta-T, M and its marketed formulation (Figure 4).
FIG. 1: OVERLAY HPTLC DENSITOGRAM OF GALLIC ACID STANDARD
FIG. 2: OVERLAY HPTLC DENSITOGRAM OF GALLIC ACID FROM SAMPLES OF ARJUNARISHTA
a, Arjunarishta-T; b, Arjunarishta-M; c, marketed Arjunarishta
FIG. 3: OVERLAY HPTLC DENSITOGRAM OF ELLAGIC ACID
FIG. 4: OVERLAY HPTLC DENSITOGRAM OF ELLAGIC ACID FROM SAMPLES OF ARJUNARISHTA
a, Arjunarishta-T; b, Arjunarishta-M; c, marketed Arjunarishta
CONCLUSION: This HPTLC technique was found to be simple, precise, specific, robust and accurate and could find application in routine quality-control analysis of Ayurvedic formulations.
REFERENCES:
- Halpern M: Ayurveda. In; Novey DW, ed. Clinician’s Complete Reference Complementary & Alternative Medicine. St. Louis, Mo; Mosby. 2000:246-257.
- Sharma HM: Maharishi Ayurveda. In: Micozzi MS, ed. Fundamentals of Complementary and Alternative Medicine. New York, NY; Churchill Livingstone Inc; 1996: 243-257.
- Rahman Z, Kohli K, Lambha HS, Rathour A and Pahwa R: An Overview of Terminalia arjuna: Chemistry and Pharmacological Profile. Indian Drugs 2004; 41(11): 641-648.
- Alberto D, Begona B and Carmen G: Antioxidant properties of commercial grape juices and vinegars. Food Chemistry 2005; 93(2):325-330.
- 5. Singh N, Kapur KK, Singh SP, Shanker K, Sinha JN and Kohli RP: Mechanism of Cardiovascular action of Terminalia arjuna. Planta Medica 1982; 45:102-104.
- Fugh BA: Herbs and Dietary supplements in prevention and treatment of cardiovascular disease prevention. Cardiol. Winter 2000; 3:24-32.
- Bharani A, Ganguli A, Mathur LK, Jamra Y and Raman PG: Efficiency of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, cross over study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart 2002; 54:170-175.
- Bharani A, Ganguli A and Bhargava K: Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 1995; 49:191-199.
- 9. Gautaman K, Banerjee SK, Dinda AK, Ghosh CC and Maulik SK: Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein. J Ethnopharmacol 2005; 96:403-409.
- 10. Khanna AK, Chander R. and Kapoor NK: Terminalia arjuna : an ayurvedic Cardiotonic, Regulates Lipid Metabolism in Hyperlipaemic Rats. Phytother Res 1996; 10:663-665.
- 11. Lal UR, Tripathi SM, Jachak SM, Bhutani KK and Singh IP: HPLC analysis and standardization of Arjunarishta- an Ayurvedic cardio protective formulation. Sci. Pharm. 2009; 77:605-616.
- 12. The Ayurvedic Formulary of India, Part-I, 2000a, 1st edition, The Controller of Publications, Delhi, 16.
- 13. Mishra S: Bhaisazya Kalpana Vigyan. Chaukambha Surbharati Prakashan, Varanasi (2005) 277-280.
- 14. Alam M, Radhamani S, Ali U and Purushottam KK: Microbiological Screening of Dhataki Flowers. J Res Ayurveda Siddha 1984; 2(4):371-375.
- 15. ICH Steering Committee: International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, validation of Analytical Procedure- Methodology, Geneva, 2006.
- 16. Singh B, Mungara P, Nivsarkar M and Anandjiwala S: HPTLC Densitometry Quantification of Glycyrrhizin, Glycyrrhizinic acid, Apigenin, Kaempferol and Quercetin from Glycyrrhiza glabra. Chromatographia 2009; 70:1665-1672.
- 17. R.P.W. Scott, Encyclopedia of Chromatography, 10th edn, Marcel Dekker, USA, 2001, 252-254.
How to cite this article:
Tiwari P and Patel RK: Quantification of Gallic Acid and Ellagic Acid in Arjunarishta by Validtaed HPTLC Densitometry. Int J Pharm Sci Res, 2012; Vol. 3(7): 2215-2223.
Article Information
48
2215-2223
736KB
1891
English
IJPSR
Preeti Tiwari* and Rakesh K. Patel
Department of Pharmacognosy, Shri Sarvajanik Pharmacy College, Mehsana-384001, Gujarat, India
13 March, 2012
18 April, 2012
22 June, 2012
http://dx.doi.org/10.13040/IJPSR.0975-8232.3(7).2215-23
01 July 2012